Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
Status:
Terminated
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bortezomib may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth. Drugs used in chemotherapy, such as fluorouracil and leucovorin, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Giving bortezomib together with fluorouracil and leucovorin may
kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving bortezomib together with
fluorouracil and leucovorin works in treating patients with metastatic or unresectable
stomach cancer.